Related Experiment Video
Updated: Feb 17, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
Adjuvanted influenza vaccines.
John S Tregoning1, Ryan F Russell1, Ekaterina Kinnear1
1a Mucosal Infection and Immunity group, Section of Virology, Department of Medicine , St Mary's Campus, Imperial College London , UK.
Influenza vaccines can be improved with adjuvants, which boost immune responses. While generally safe, rare adverse events and viral evolution necessitate ongoing research for better universal influenza vaccines.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- Influenza virus evolution reduces vaccine efficacy, posing a significant public health threat.
- Adjuvants enhance immune responses, crucial for pandemic preparedness and vulnerable populations like infants and the elderly.
Purpose of the Study:
- To review the current use, mechanisms, and safety of adjuvants in human influenza vaccines.
- To discuss experimental adjuvants and their potential role in future influenza vaccine development.
Main Methods:
- Literature review of licensed and experimental adjuvants for influenza vaccines.
- Analysis of adjuvant mechanisms of action and clinical trial data.
Main Results:
- Six adjuvants (Alum, MF59, AS03, AF03, virosomes, LT) are licensed for human influenza vaccines.
- Most adjuvants are safe and well-tolerated, though rare adverse events (e.g., LT and Bell's Palsy) have been reported.
Conclusions:
- Adjuvants can enhance influenza vaccine efficacy, particularly for next-generation and universal vaccines.
- Further research is needed to optimize adjuvant use and address viral evolution challenges.
Related Concept Videos
Vaccinations
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

